1. Market Overview of IBS-C Drugs
1.1 IBS-C Drugs Market Overview
1.1.1 IBS-C Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 IBS-C Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 IBS-C Drugs Historic Market Size by Regions (2015-2020)
1.4 IBS-C Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact IBS-C Drugs Sales Market by Type (2015-2026)
2.1 Global IBS-C Drugs Historic Market Size by Type (2015-2020)
2.2 Global IBS-C Drugs Forecasted Market Size by Type (2021-2026)
2.3 Linaclotide
2.4 Lubiprostone
2.5 Osmotic Laxatives
2.6 Stimulant Laxatives
2.7 Others
3. Covid-19 Impact IBS-C Drugs Sales Market by Application (2015-2026)
3.1 Global IBS-C Drugs Historic Market Size by Application (2015-2020)
3.2 Global IBS-C Drugs Forecasted Market Size by Application (2021-2026)
3.3 Hospital Pharmacies
3.4 Retail Pharmacies
3.5 Online Pharmacies
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global IBS-C Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global IBS-C Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global IBS-C Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in IBS-C Drugs Business
5.1 Catalent Pharmaceuticals Solutions
5.1.1 Catalent Pharmaceuticals Solutions Company Profile
5.1.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Specification
5.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Nestle
5.2.1 Nestle Company Profile
5.2.2 Nestle IBS-C Drugs Product Specification
5.2.3 Nestle IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Company Profile
5.3.2 Abbott Laboratories IBS-C Drugs Product Specification
5.3.3 Abbott Laboratories IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Synergy Pharmaceuticals
5.4.1 Synergy Pharmaceuticals Company Profile
5.4.2 Synergy Pharmaceuticals IBS-C Drugs Product Specification
5.4.3 Synergy Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Sucampo Pharmaceuticals
5.5.1 Sucampo Pharmaceuticals Company Profile
5.5.2 Sucampo Pharmaceuticals IBS-C Drugs Product Specification
5.5.3 Sucampo Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novartis Pharma Ag
5.6.1 Novartis Pharma Ag Company Profile
5.6.2 Novartis Pharma Ag IBS-C Drugs Product Specification
5.6.3 Novartis Pharma Ag IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Astellas Pharmaceuticals
5.7.1 Astellas Pharmaceuticals Company Profile
5.7.2 Astellas Pharmaceuticals IBS-C Drugs Product Specification
5.7.3 Astellas Pharmaceuticals IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Ardelyx Inc
5.8.1 Ardelyx Inc Company Profile
5.8.2 Ardelyx Inc IBS-C Drugs Product Specification
5.8.3 Ardelyx Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Synthetic Biologics Inc
5.9.1 Synthetic Biologics Inc Company Profile
5.9.2 Synthetic Biologics Inc IBS-C Drugs Product Specification
5.9.3 Synthetic Biologics Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Teva Pharmaceutical Industries
5.10.1 Teva Pharmaceutical Industries Company Profile
5.10.2 Teva Pharmaceutical Industries IBS-C Drugs Product Specification
5.10.3 Teva Pharmaceutical Industries IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Bama-Geve
5.11.1 Bama-Geve Company Profile
5.11.2 Bama-Geve IBS-C Drugs Product Specification
5.11.3 Bama-Geve IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 SLU
5.12.1 SLU Company Profile
5.12.2 SLU IBS-C Drugs Product Specification
5.12.3 SLU IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Ferring BV
5.13.1 Ferring BV Company Profile
5.13.2 Ferring BV IBS-C Drugs Product Specification
5.13.3 Ferring BV IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Ironwood Pharmaceuticals Inc
5.14.1 Ironwood Pharmaceuticals Inc Company Profile
5.14.2 Ironwood Pharmaceuticals Inc IBS-C Drugs Product Specification
5.14.3 Ironwood Pharmaceuticals Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Salix Pharmaceuticals Ltd
5.15.1 Salix Pharmaceuticals Ltd Company Profile
5.15.2 Salix Pharmaceuticals Ltd IBS-C Drugs Product Specification
5.15.3 Salix Pharmaceuticals Ltd IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Norgine B.V
5.16.1 Norgine B.V Company Profile
5.16.2 Norgine B.V IBS-C Drugs Product Specification
5.16.3 Norgine B.V IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Prometheus Laboratories Inc
5.17.1 Prometheus Laboratories Inc Company Profile
5.17.2 Prometheus Laboratories Inc IBS-C Drugs Product Specification
5.17.3 Prometheus Laboratories Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Actavis Nordic A/S
5.18.1 Actavis Nordic A/S Company Profile
5.18.2 Actavis Nordic A/S IBS-C Drugs Product Specification
5.18.3 Actavis Nordic A/S IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Albireo Pharma Inc
5.19.1 Albireo Pharma Inc Company Profile
5.19.2 Albireo Pharma Inc IBS-C Drugs Product Specification
5.19.3 Albireo Pharma Inc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Yuhan Corp
5.20.1 Yuhan Corp Company Profile
5.20.2 Yuhan Corp IBS-C Drugs Product Specification
5.20.3 Yuhan Corp IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Astrazeneca Plc
5.21.1 Astrazeneca Plc Company Profile
5.21.2 Astrazeneca Plc IBS-C Drugs Product Specification
5.21.3 Astrazeneca Plc IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 The Menarini Group
5.22.1 The Menarini Group Company Profile
5.22.2 The Menarini Group IBS-C Drugs Product Specification
5.22.3 The Menarini Group IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Ono Pharmaceutical Co. Ltd
5.23.1 Ono Pharmaceutical Co. Ltd Company Profile
5.23.2 Ono Pharmaceutical Co. Ltd IBS-C Drugs Product Specification
5.23.3 Ono Pharmaceutical Co. Ltd IBS-C Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America IBS-C Drugs Market Size (2015-2026)
6.2 North America IBS-C Drugs Key Players in North America (2015-2020)
6.3 North America IBS-C Drugs Market Size by Type (2015-2020)
6.4 North America IBS-C Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia IBS-C Drugs Market Size (2015-2026)
7.2 East Asia IBS-C Drugs Key Players in North America (2015-2020)
7.3 East Asia IBS-C Drugs Market Size by Type (2015-2020)
7.4 East Asia IBS-C Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe IBS-C Drugs Market Size (2015-2026)
8.2 Europe IBS-C Drugs Key Players in North America (2015-2020)
8.3 Europe IBS-C Drugs Market Size by Type (2015-2020)
8.4 Europe IBS-C Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia IBS-C Drugs Market Size (2015-2026)
9.2 South Asia IBS-C Drugs Key Players in North America (2015-2020)
9.3 South Asia IBS-C Drugs Market Size by Type (2015-2020)
9.4 South Asia IBS-C Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia IBS-C Drugs Market Size (2015-2026)
10.2 Southeast Asia IBS-C Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia IBS-C Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia IBS-C Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East IBS-C Drugs Market Size (2015-2026)
11.2 Middle East IBS-C Drugs Key Players in North America (2015-2020)
11.3 Middle East IBS-C Drugs Market Size by Type (2015-2020)
11.4 Middle East IBS-C Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa IBS-C Drugs Market Size (2015-2026)
12.2 Africa IBS-C Drugs Key Players in North America (2015-2020)
12.3 Africa IBS-C Drugs Market Size by Type (2015-2020)
12.4 Africa IBS-C Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania IBS-C Drugs Market Size (2015-2026)
13.2 Oceania IBS-C Drugs Key Players in North America (2015-2020)
13.3 Oceania IBS-C Drugs Market Size by Type (2015-2020)
13.4 Oceania IBS-C Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America IBS-C Drugs Market Size (2015-2026)
14.2 South America IBS-C Drugs Key Players in North America (2015-2020)
14.3 South America IBS-C Drugs Market Size by Type (2015-2020)
14.4 South America IBS-C Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World IBS-C Drugs Market Size (2015-2026)
15.2 Rest of the World IBS-C Drugs Key Players in North America (2015-2020)
15.3 Rest of the World IBS-C Drugs Market Size by Type (2015-2020)
15.4 Rest of the World IBS-C Drugs Market Size by Application (2015-2020)
16 IBS-C Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.